Product Reports Resources Pricing Login Book a demo

Beam Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2017 · IPO 2020

developing precision genetic medicines for serious diseases

Valuation $1.66B
Revenue $79M
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Talent graph

Beam Therapeutics's talent

Book a demo to see the people
Employees mapped 600 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on Beam Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 10 investors entered at this stage
Cormorant Asset Management
Altitude Life Science Ventures
F-Prime
Harvard University
Omega Funds
Dreamers
Redmile Group
DHVC
ARCH Venture Partners
Eight Roads Ventures

Beam Therapeutics mafia

Startups founded by Beam Therapeutics alumni

Former Beam Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.

PairwiseEst. 2017
David LiuUnited States
Signal score77
Prime MedicineEst. 2019
DLDavid R. LiuUnited States
Signal score64
Verve TherapeuticsEst. 2018
Keith JoungUnited States
Signal score64
Orbital TherapeuticsEst. 2022
GCGiuseppe CiaramellaUnited States
Signal score62

Book a demo to explore the full alumni network →

Global footprint

Where Beam Therapeutics has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States99.5%
🇵🇹 Portugal0.2%
🏳️ Liechtenstein0.2%
3 countries shown
Web traffic by country
53K monthly visits
across markets
🇺🇸 United States61.5%
🇮🇳 India10.2%
🇨🇦 Canada5.7%
🏳️ Korea5.7%
🏳️ Republic of4.5%
Top 5 markets shown

Patent intelligence

$23M patent portfolio · 90 active families

Estimated portfolio value
$23M
1.4% of market cap · 7.2× smaller than top peer Lexicon Pharmaceuticals ($166M)
90 active patent families
Where Beam Therapeutics innovates Cell biologyNucleic acidAdenosine deaminaseBase JBioinformatics

Where Beam Therapeutics concentrates vs peers

Each axis is a top-10 topic across Beam Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Beam Therapeutics

An AI-synthesized read of the highest-engagement posts about Beam Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Beam Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles